DeutschNewstral
Article
WHIO on 2015-04-21 23:38
Teva Offers $40 Billion for Mylan
Related news
Teva Offers to Buy Mylan for $40 Billionwsj.com
Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com
Teva offers to buy Mylan in $40 billion dealtimesofisrael.com- Bloomberg: Teva to sweeten bid for Mylanbizjournals.com
- Report: Teva getting ready to up its offer for Mylanbizjournals.com
- Teva brings in new advisor for proposed Mylan dealbizjournals.com
- Teva makes unsolicited $82-a-share offer for Mylanbizjournals.com
- Teva brings in new adviser for proposed Mylan dealbizjournals.com
Teva offers to buy Mylan for $40.1Bobserver-reporter.com
Teva offers to buy Mylan in $40.1B cash-and-stock dealTimesDaily.com- Teva ups stake in Mylanbizjournals.com
- Teva steadily increases Mylan stakebizjournals.com
Teva buying Auspex Pharmaceuticals for $3.2-billionThe Globe and Mail
Teva Hopes $40 Billion Mylan Deal Will Fuel Stock ReboundForbes- Video: Teva buys Allergan for $40.5-billionThe Globe and Mail
- GRevenue Growth Predicted for Sertraline HCl API Market by 2028 Teva,Mylangalleonnews.com
- Teva takes its case for buying Mylan to the company's stockholdersbizjournals.com
- With Teva out of the way, stage set for Mylan to make new go at Perrigobizjournals.com
- Teva makes $40.1-billion unsolicited takeover bid for MylanThe Globe and Mail
- CTeva offers to buy drugmaker Mylan for $40.1Bcontracostatimes.com